AXILLARY LYMPHADENECTOMY

AXILLARY LYMPHADENECTOMY was reported 78 times

AXILLARY LYMPHADENECTOMY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Microtubule Inhibitor [EPC] 28 0.0002
1 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 3 0.0001
2 HER2/neu Receptor Antagonist [EPC] 7 0.0001
3 Platinum-based Drug [EPC] 21 0.0001
4 Alkylating Drug [EPC] 13 0.0001
5 Progesterone [EPC] 1 0.0000
6 Cardiac Glycoside [EPC] 3 0.0000
7 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 2 0.0000
8 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 3 0.0000
9 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
10 RANK Ligand Inhibitor [EPC] 5 0.0000
11 Aromatase Inhibitor [EPC] 2 0.0000
12 Methylxanthine [EPC] 1 0.0000
13 BCL-2 Inhibitor [EPC] 1 0.0000
14 Topoisomerase Inhibitor [EPC] 1 0.0000
15 Nucleoside Analog Antiviral [EPC] 1 0.0000
16 Central Nervous System Stimulant [EPC] 1 0.0000
17 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
18 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
19 beta-Adrenergic Blocker [EPC] 3 0.0000
20 Loop Diuretic [EPC] 4 0.0000
21 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
22 Factor Xa Inhibitor [EPC] 2 0.0000
23 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
24 alpha-Adrenergic Blocker [EPC] 1 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
26 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
27 Opioid Agonist [EPC] 1 0.0000
28 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
29 Kinase Inhibitor [EPC] 2 0.0000
30 Progestin [EPC] 1 0.0000
31 Proton Pump Inhibitor [EPC] 2 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Benzodiazepine [EPC] 2 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 1 0.0000